Mitogen-Activated Protein Kinase Signaling Mediates Morphine Induced-Delayed Hyperalgesia

Overview

Journal Front Neurosci

Date 2019 Oct 17

PMID 31616243

Citations 8

Authors

Barbara Guimaraes de Freitas

Leandro Marcio Pereira

Flavia Vianna Santa-Cecilia

Natalia Gabriele Hosch

Gisele Picolo

Yara Cury

Vanessa O Zambelli

Affiliations

Soon will be listed here.

Abstract

The use of morphine, the standard opioid drug, is limited by its undesirable effects, such as tolerance, physical dependence, and hyperalgesia (increased pain sensitivity). Clinical and preclinical studies have reported development of hyperalgesia after prolonged opioid administration or after a single dose of intrathecal (i.t.) morphine in uninjured rats. However, whether a single standard systemic morphine dose is sufficient to decrease the nociceptive threshold in rats is unknown. Here, we showed that a single morphine subcutaneous injection induces analgesia followed by a long-lasting delayed hyperalgesia in uninjured and PGE2 sensitized rats. The i.t injection of extracellular signal-regulated kinase (ERK) inhibitor blocked morphine-induced analgesia, without interfering with the morphine-induced hyperalgesia. However, i.t. injection of SB20358, a p38 inhibitor and SP660125, a JNK inhibitor, decreased the morphine-induced hyperalgesia. Consistently with the behavioral data, Western Blot analysis showed that ERK is more phosphorylated 1 h after morphine, i.e., when the analgesia is detected. Moreover, phospho-p38 and phospho-JNK levels are upregulated 96 h after morphine injection, time that coincides with the hyperalgesic effect. Intrathecal (i.t.) oligodeoxynucleotide (ODN) antisense to cAMP-responsive element binding protein (CREB) attenuated morphine-induced hyperalgesia. Real-time polymerase chain reaction (RT-PCR) analysis showed that CREB downstream genes expressions were significantly up-regulated 96 h after morphine injection in spinal cord. Together, our data suggest that central ERK is involved in the analgesic and hyperalgesic effects of morphine while JNK, p38, and CREB are involved in the morphine-induced delayed hyperalgesia.

Citing Articles

Epigenetic regulation in opioid induced hyperalgesia.

Reddy D, Wickman J, Ajit S Neurobiol Pain. 2023; 14:100146.

PMID: 38099284 PMC: 10719581. DOI: 10.1016/j.ynpai.2023.100146.

Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk.

Newman M, Connery H, Boyd J Antioxidants (Basel). 2022; 11(7).

PMID: 35883757 PMC: 9312198. DOI: 10.3390/antiox11071267.

Blocking of Caveolin-1 Attenuates Morphine-Induced Inflammation, Hyperalgesia, and Analgesic Tolerance via Inhibiting NLRP3 Inflammasome and ERK/c-JUN Pathway.

Liu W, Jiang P, Qiu L J Mol Neurosci. 2022; 72(5):1047-1057.

PMID: 35262905 DOI: 10.1007/s12031-022-01989-w.

PKCζ-Mitogen-Activated Protein Kinase Signaling Mediates Crotalphine-Induced Antinociception.

de Freitas B, Hosch N, Pereira L, Barbosa T, Picolo G, Cury Y Toxins (Basel). 2021; 13(12).

PMID: 34941749 PMC: 8709465. DOI: 10.3390/toxins13120912.

Acute morphine blocks spinal respiratory motor plasticity via long-latency mechanisms that require toll-like receptor 4 signalling.

Tadjalli A, Seven Y, Sharma A, McCurdy C, Bolser D, Levitt E J Physiol. 2021; 599(15):3771-3797.

PMID: 34142718 PMC: 8437142. DOI: 10.1113/JP281362.

References

Zambelli V, Fernandes A, Gutierrez V, Ferreira J, Parada C, Mochly-Rosen D . Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats. PLoS One. 2014; 9(3):e90576. PMC: 3942445. DOI: 10.1371/journal.pone.0090576. View

Yalcin I, Charlet A, Freund-Mercier M, Barrot M, Poisbeau P . Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents. J Pain. 2009; 10(7):767-73. DOI: 10.1016/j.jpain.2009.01.325. View

Horvath R, Landry R, Romero-Sandoval E, DeLeo J . Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation. Neuroscience. 2010; 169(2):843-54. PMC: 2904400. DOI: 10.1016/j.neuroscience.2010.05.030. View

Chen Y, Geis C, Sommer C . Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci. 2008; 28(22):5836-45. PMC: 6670790. DOI: 10.1523/JNEUROSCI.4170-07.2008. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Ji R, Gereau 4th R, Malcangio M, Strichartz G . MAP kinase and pain. Brain Res Rev. 2009; 60(1):135-48. PMC: 2666786. DOI: 10.1016/j.brainresrev.2008.12.011. View

Vivancos G, Verri Jr W, Cunha T, Schivo I, Parada C, Cunha F . An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res. 2004; 37(3):391-9. DOI: 10.1590/s0100-879x2004000300017. View

Lee M, Silverman S, Hansen H, Patel V, Manchikanti L . A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011; 14(2):145-61. View

Chen Y, Sommer C . The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol. 2009; 40(2):101-7. DOI: 10.1007/s12035-009-8074-z. View

10.

Johnson G, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298(5600):1911-2. DOI: 10.1126/science.1072682. View

11.

Alshahrani S, Fernandez-Conti F, Araujo A, DiFulvio M . Rapid determination of the thermal nociceptive threshold in diabetic rats. J Vis Exp. 2012; (63):e3785. PMC: 3466937. DOI: 10.3791/3785. View

12.

Angst M, Koppert W, Pahl I, Clark D, Schmelz M . Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003; 106(1-2):49-57. DOI: 10.1016/s0304-3959(03)00276-8. View

13.

Rivat C, Ballantyne J . The dark side of opioids in pain management: basic science explains clinical observation. Pain Rep. 2018; 1(2):e570. PMC: 5741356. DOI: 10.1097/PR9.0000000000000570. View

14.

Ji R, Strichartz G . Cell signaling and the genesis of neuropathic pain. Sci STKE. 2004; 2004(252):reE14. DOI: 10.1126/stke.2522004re14. View

15.

Angst M, Clark J . Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006; 104(3):570-87. DOI: 10.1097/00000542-200603000-00025. View

16.

Basbaum A, Bautista D, Scherrer G, Julius D . Cellular and molecular mechanisms of pain. Cell. 2009; 139(2):267-84. PMC: 2852643. DOI: 10.1016/j.cell.2009.09.028. View

17.

Wang Z, Ma W, Chabot J, Quirion R . Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J. 2009; 23(8):2576-86. DOI: 10.1096/fj.08-128348. View

18.

Ferrari L, Araldi D, Bogen O, Green P, Levine J . Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity. Neuroscience. 2018; 398:64-75. PMC: 9948647. DOI: 10.1016/j.neuroscience.2018.11.051. View

19.

RANDALL L, SELITTO J . A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957; 111(4):409-19. View

20.

Corder G, Tawfik V, Wang D, Sypek E, Low S, Dickinson J . Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nat Med. 2017; 23(2):164-173. PMC: 5296291. DOI: 10.1038/nm.4262. View